| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.72B | 35.62B | 30.93B | 22.51B | 27.32B | 17.63B |
| Gross Profit | 8.65B | 7.77B | 5.75B | 4.74B | 6.21B | 2.84B |
| EBITDA | 9.24B | 8.43B | 7.01B | 5.93B | 7.01B | 3.54B |
| Net Income | 1.74B | 1.23B | -2.23B | 857.70M | 2.42B | 217.82M |
Balance Sheet | ||||||
| Total Assets | 71.82B | 72.78B | 74.84B | 84.05B | 78.71B | 77.92B |
| Cash, Cash Equivalents and Short-Term Investments | 21.54B | 21.21B | 16.58B | 16.98B | 26.87B | 21.90B |
| Total Debt | 20.87B | 21.36B | 25.37B | 33.22B | 28.05B | 33.20B |
| Total Liabilities | 28.75B | 30.51B | 34.52B | 42.38B | 38.51B | 40.47B |
| Stockholders Equity | 36.84B | 36.24B | 35.18B | 37.55B | 36.91B | 34.62B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.47B | 7.34B | -14.25B | 11.38B | -5.33B |
| Operating Cash Flow | 0.00 | 15.43B | 10.90B | -12.45B | 13.16B | -1.45B |
| Investing Cash Flow | 0.00 | -6.72B | -3.38B | -2.54B | -2.44B | -3.93B |
| Financing Cash Flow | 0.00 | -4.27B | -7.93B | 4.91B | -5.21B | 4.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥36.28B | 9.47 | ― | 3.63% | 2.20% | 2.39% | |
72 Outperform | ¥34.86B | 7.15 | ― | 0.93% | 10.22% | ― | |
67 Neutral | ¥265.59B | 29.55 | ― | 1.51% | 11.92% | 33.70% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | ¥114.53B | 32.53 | ― | ― | 62.69% | -37.72% | |
52 Neutral | ¥49.75B | 49.41 | ― | ― | 6.00% | -184.09% | |
42 Neutral | ¥58.97B | -0.27 | -78.01% | ― | -14.08% | 54.85% |